In contrast, interventional embolization-induced hypoxia inhibits METTL14 in a HIF-1α-dependent manner and subsequently blocks METTL14/YTHDF2/SLC7A11/ROS axis-mediated ferroptosis, promoting HCC progression. Here, YTHDF2 is linked to hepatocellular carcinoma.